Methylphenidate is a psycho stimulant drug for the treatment of attention-deficit hyperactivity disorder, Postural Orthostatic Tachycardia Syndrome, and narcolepsy. Methylphenidate increases dopamine levels. The abuse potential is increased when methylphenidate is crushed and snorted or when it is injected producing effects almost identical to cocaine. Cocaine-like effects can also occur with very large doses taken orally. Methylphenidate has a high potential for drug dependence and addictive abuse due to its similar pharmacological relationship to cocaine and amphetamines. Internationally, methylphenidate is a Schedule II drug under the Convention on Psychotropic Substances. In the United States, methylphenidate is classified as a Schedule II controlled substance, the designation used for substances that have a recognized medical value but present a high likelihood for abuse because of their addictive potential.

Methylphenidate is most commonly known by the Novartis trademark name Ritalin, which is an instant-release racemic mixture. There are also a variety of formulations and generic brand in existence. It may also be prescribed for off-label use in treatment-resistant cases of lethargy, depression, neutral insult, obesity, and rarely in other psychiatric disorders such as Obsessive-Compulsive Disorder.
Methylphenidate (MPD) Drug Test is an immunochromatography-based one step in vitro test. It is designed for qualitative determination of methylphenidate in human urine specimens at cut-off level of 300 ng/ml. This assay has not been evaluated in the point of care location and is for use by Healthcare Professionals only. This drug test is available in cassette and strip test format.

Methylphenidate Drug test provides only a preliminary analytical drug test result.  A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography / Mass Spectrometry (GC/MS) has been established as the preferred confirmatory method by the Substance Abuse Mental Health Services Administration (SAMHSA). Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

The Diagnostic Automation / Cortez Diagnostics,Inc. offer the following Drug tests in Strip and Cassette format. The Drug tests can be customized according to your needs for sensitivities and combination (up to 10) of different drug test panels. Our drug tests can be offer in single drug test or in multi drug tests. We manufacture drug tests with good high quality, Our rapid tests are FDA,CE,ISO approved.

Alcohol Drug Tests

Amphetamine  Drug Test

Barbiturate Drug Test

Benzodiazepine Drug Test

Buprenorphine Drug Test

Cocaine Drug Test

EDDP Drug Test

Ketamine Drug Test

Methadone Drug Test

Methamphetamine (includes Ecstasy) Drug Test

MDMA (Ecstasy specific) Drug Test

Opiate Drug Test

Oxycodone Drug Test

Phencyclidine Drug Test

Tramadol Drug Test

Tricyclic antidepressant (TCA) Drug Test